Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13333913 | 0.99 | PDK2 (0.31) | PDK2SIGMAR1 | |
| SCHEMBL13333763 | 0.97 | PDK2 (0.31) | PDK2SIGMAR1 | |
| SCHEMBL12014685 | 0.95 | SIGMAR1 (0.32) | PDK2SIGMAR1 | |
| SCHEMBL13766286 | 0.94 | SIGMAR1 (0.32) | SIGMAR1 | |
| SCHEMBL13333986 | 0.93 | MCL1 (0.32) | SIGMAR1 | |
| SCHEMBL10153150 | 0.92 | SIGMAR1 (0.34) | PDK2SIGMAR1 | |
| SCHEMBL15081536 | 0.91 | PDK2 (0.33) | PDK2 | |
| SCHEMBL13333598 | 0.91 | PIM1 (0.30) | SIGMAR1 | |
| SCHEMBL12770684 | 0.91 | CA12 (0.33) | PDK2 | |
| SCHEMBL12770689 | 0.91 | DHFR (0.31) | PDK2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, ORMDL3, CHRM2 | PDK2 2656/4885SIGMAR1 966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.